Litseglutine B exhibits potential in pharmaceutical research due to its structural features linked to bioactive glutin compounds. It has been investigated for its anti-inflammatory and neuroprotective properties, making it a candidate for studies related to neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. Preliminary in vitro studies suggest it may modulate cellular pathways involved in oxidative stress and neuronal survival. Additionally, its natural origin and unique amide structure support exploration in drug discovery for central nervous system targets. Further research is needed to evaluate its pharmacokinetics and therapeutic efficacy in vivo.